The natural product industry is booming and showing no signs of slowing. Big brands are taking note by scooping up smaller, innovative companies that are disrupting consumer products by adding a natural twist. Michael Cammarata, Co-Founder and CEO of Schmidt's Naturals, shared why his company was such an attractive target for Unilever.
Cammarata said Unilever was drawn to his brand due to its rapid growth and ability to go to market quickly. He said consumers have been the brands biggest advocate. The entrepreneur also added that the Unilever focuses on the founders and allows them to continue to operate the way they want.
All-natural has been all the rage as consumers increasingly opt for chemical-free products. He says his brand is unique because they focused on competing with brands in the traditional space. He added consumers are realizing products with natural ingredients are delivering similar results as the initial products.
Some House Democrats will have to vote for McCarthy's bill if enough conservative Republicans keep their word to oppose any compromise.
Blue Bird, a maker of school buses, opened up a production facility to meet the rising demand for electric school buses.
The National Eating Disorders Association said it's replacing its staff with an artificial intelligence chatbot.
Hyundai and LG announced a partnership to build a $4.3 billion electric battery plant in Georgia.
JPMorgan announced job cuts at First Republic Bank, a month after acquiring the company.
AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
The federal government is giving away for free some historic lighthouses and is also auctioning some of them off too.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Elon Musk's brain-implant company Neuralink said it received approval from the Food and Drug Administration to begin human clinical trials.
Aileen Del Cid, head of marketing at Samsung TV Plus, sat down with Cheddar News reporter Michelle Castillo to discuss the platform's plans to stand out from the streaming competition with a new channel featuring Conan O'Brien.
